Inflammatory pathways in patients with heart failure and preserved ejection fraction

Author(s): Niethammer M, Sieber M, von Haehling S, Anker SD, Munzel T, et al.

Abstract

Immune activation is well established in patients with chronic heart failure and reduced ejection fraction (HF and reduced EF) and is associated with an impaired prognosis. Patients with heart failure and preserved ejection fraction (HF and preserved EF) have an impaired prognosis as well. It is not known whether they have signs of immune activation.

Methods:We studied patients with HF and preserved EF (n=17, NYHA II [n=7]/III [n=10]) and patients with HF and reduced EF (n=17 NYHA II [n=1]/III [n=16]) and 20 controls. Echocardiography demonstrated preserved ejection fraction (LVEF 59+/-9%), but LV hypertrophy in patients with preserved EF as compared with patients with reduced EF (LVEF 23+/-5%). We evaluated levels of TNFalpha, its receptors (sTNFR-1 and 2), IL-6, IL-10 and NT-proBNP.

Results:TNFalpha, was highest in HF with reduced EF (2.87+/-0.65 vs 1.67+/-0.58 pg/mL, p<0.001) compared to preserved EF and similar between HF with preserved EF and controls. However, sTNFR1 (1618+/-384 vs 1017+/-302 pg/mL, p<0.001) and sTNFR2 levels (3554+/-916 vs 2041+/-586 pg/mL, p<0.001) in HF with preserved EF were significantly higher compared with controls. The same was true for IL-6, IL-10 and NT-proBNP. The highest cytokine and NT-proBNP levels were present in HF with reduced EF. There was a negative correlation between TNFalpha, and LVEF (r=- 0.700; p<0.0001) and positive correlations between sTNFR1 and 2 with NT-proBNP.

Conclusion:Patients with HF and preserved EF already show signs of systemic-immune activation which may contribute to the impaired prognosis and the progression to HF with reduced EF.

Similar Articles

Omics meets hypothesisdriven research

Author(s): Ruegg C, Tissot JD, Farmer P, Mariotti A

Trends in prevalence and outcome of heart failure with preserved ejection fraction

Author(s): Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, et al.

Outcome of heart failure with preserved ejection fraction in a population-based study

Author(s): Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, et al.

Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction

Author(s): Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, et al.

Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction

Author(s): Gonzalez A, Lopez B, Querejeta R, Zubillaga E, Echeverria T, et al.

Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey

Author(s): Lenzen MJ, Scholte op Reimer WJ, Boersma E, Vantrimpont PJ, Follath F, et al.

The perindopril in elderly people with chronic heart failure (PEP-CHF) study

Author(s): Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, et al.

Proteomic analysis of left ventricular diastolic dysfunction hearts in renovascular hypertensive rats

Author(s): Junhong W, Jing Y, Jizheng M, Shushu Z, Xiangjian C, et al.

Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness

Author(s): Levy D, Larson MG, Benjamin EJ, Newton-Cheh C, Wang TJ, et al.

Genome-wide association study identifies eight loci associated with blood pressure

Author(s): Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, et al.

Genome-wide association study of blood pressure and hypertension

Author(s): Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, et al.

Initial sequencing and analysis of the human genome

Author(s): Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al.

A second generation human haplotype map of over 3

Author(s): Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al.

Plasma cytokine parameters and mortality in patients with chronic heart failure

Author(s): Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, et al.

Colocalization of myocardial fibrosis and inflammatory cells in rats

Author(s): Hinglais N, Heudes D, Nicoletti A, Mandet C, Laurent M, et al.

Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction

Author(s): Martos R, Baugh J, Ledwidge M, O'Loughlin C, Conlon C, et al.

Sex-specific pathways in early cardiac response to pressure overload in mice

Author(s): Witt H, Schubert C, Jaekel J, Fliegner D, Penkalla A, et al.

Sex-dependent differences in left ventricular function and structure in chronic pressure overload

Author(s): Villari B, Campbell SE, Schneider J, Vassalli G, Chiariello M, et al.

Sex-dependent differences in left ventricular function and structure in chronic pressure overload

Author(s): Villari B, Campbell SE, Schneider J, Vassalli G, Chiariello M, et al.

Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs

Author(s): Kruger M, Kotter S, Grutzner A, Lang P, Andresen C, et al.

Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium

Author(s): Borbely A, Falcao-Pires I, van Heerebeek L, Hamdani N, Edes I, et al.

PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness

Author(s): Hidalgo C, Hudson B, Bogomolovas J, Zhu Y, Anderson B, et al.

Role of extracellular matrix in vascular remodeling of hypertension

Author(s): riones AM, Arribas SM, Salaices M

Left ventricular diastolic parameters in 288 normal subjects from 20 to 80 years old

Author(s): Mantero A, Gentile F, Gualtierotti C, Azzollini M, Barbier P, et al.

Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction

Author(s): Silberman GA, Fan TH, Liu H, Jiao Z, Xiao HD, et al.

Sex Differences in Sympathetic Neural-Hemodynamic Balance: implications for human blood pressure regulation

Author(s): Hart EC, Charkoudian N, Wallin GG, Curry TB, Eisenach JH, et al.

Cytoscape: a software environment for integrated models of biomolecular interaction networks

Author(s): Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al.